<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03090594</url>
  </required_header>
  <id_info>
    <org_study_id>CB JKMT-2</org_study_id>
    <nct_id>NCT03090594</nct_id>
  </id_info>
  <brief_title>Transbronchial Cryobiopsy in Lung Transplant Patients</brief_title>
  <official_title>Diagnostic Performance and Complications of Transbronchial Cryobiopsy in Lung Transplant Patients According to the Number of Samples Obtained</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cryobiopsy has displaced the transbronchial biopsy (BTB) with forceps because it allows to
      obtain samples of more representative pulmonary parenchyma with more alveoli, less artifacts
      and a greater diagnostic yield. However, some authors report an increase in adverse effects
      such as hemorrhage and pneumothorax. The latest ISHLT (International Society for Heart and
      Lung Transplantation) consensus of 2007 recommends that with BTB with forceps a minimum of
      five tissue samples should be obtained that should contain more than 100 wells or the
      presence of two bronchioles to Which may be necessary between 3 and 17 samples. The optimal
      number of transbronchial cryobiopsies is unknown in order to obtain maximum performance with
      the lowest possible morbidity.

      It is proposed to analyze the morphological and histopathological characteristics of each
      cryobiopsies individually and in order of extraction, to determine the sensitivity in the
      diagnosis of acute rejection as a function of the number of samples. Lung transplant
      patients, not admitted to critical units, with BTB indication will be included. A maximum of
      6 samples will be obtained by flexible bronchoscope and under general anesthesia.

      These data will allow to know the minimum number of specimens that guarantee a histological
      and / or bacteriological diagnosis of certainty with maximum effectiveness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transbronchial biopsies (BPTB) will be performed using a flexible bronchoscope and the biopsy
      will be performed with cryoprobe (Erbokryo®). The patient undergoing the procedure will be
      intubated, sedated and relaxed under continuous monitoring (pulse oximetry, blood pressure,
      heart and respiratory rate), oxygen therapy with high flows and surveillance by
      anesthesiologist. The site where the biopsies will be performed will be determined based on
      an imaging study (chest x-ray and / or CT scan). The procedure will be performed according to
      the conventional technique, keeping the patient in apnea during the time that the
      cryobiopsies are taken to reduce the risk of pneumothorax. At most 6 samples will be
      obtained, and each one will be placed in an individual container listed in order of
      extraction. Bronchoalveolar lavage (3 aliquots of 30 mL sterile saline solution) will be
      performed in the same hemithorax. The samples obtained will be evaluated morphologically and
      sent to a microbiological and histopathological study, which will include a cell count. The
      data obtained will be coded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">September 17, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of transbronchial biopsies with which a pathological diagnosis is obtained. The rejection graduation according to the criteria of the International Society for Heart Lung Transplantation (ISHLT).</measure>
    <time_frame>5-7 days.</time_frame>
    <description>A maximum of 6 samples will be obtained.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of alveoli, bronchi, bronchioles, blood vessels and pleura containing each biopsy.</measure>
    <time_frame>30 days.</time_frame>
    <description>The Mese Software will be used. ¨Leica Application Suite X¨.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of complications related to the procedure.</measure>
    <time_frame>30 days.</time_frame>
    <description>Complications related to the procedure: bleeding, pneumothorax, pneumonia, acute respiratory failure or need for hospitalization.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Lung Transplantation</condition>
  <arm_group>
    <arm_group_label>Biopsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Transbronchial biopsies with cryoprobe.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>Is to obtain pulmonary parenchyma samples using a flexible bronchoscope.</description>
    <arm_group_label>Biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pulmonary transplant patients with suspected rejection or infection requiring
             transbronchial biopsy

        Exclusion Criteria:

          -  Respiratory failure refractory to oxygen therapy.

          -  Acute or subacute ischemic heart disease (last 4-6 weeks).

          -  Severe arrhythmias.

          -  Coagulation disorders: platelets &lt;60,000-50,000 or Prothrombin time &lt;60%.

          -  Lack of consent informed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier De Gracia, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Respiratory department.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karina Loor, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Respiratory department.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Culebras, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Respiratory department.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Álvarez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Respiratory department.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karina Loor, MD</last_name>
    <phone>93 274 6138</phone>
    <email>kloor@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Javier De Gracia, MD PhD</last_name>
    <phone>93 274 6138</phone>
    <email>jgracia.jgracia@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Vall de Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karina Loor, MD</last_name>
      <phone>93 274 6138</phone>
      <email>kloor@vhebron.net</email>
    </contact>
    <contact_backup>
      <last_name>Javier De Gracia, MD</last_name>
      <phone>93 274 6138</phone>
      <email>jgracia.jgracia@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Karina Loor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mario Culebras, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Álvarez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cryoprobe</keyword>
  <keyword>Bronchoscopy</keyword>
  <keyword>Acute cellular rejection</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

